Vulva choriocarcinoma
Houssine Boufettal
The Pan African Medical Journal. ;24:328. doi:10.11604/pamj..24.328.10482

Create an account  |  Sign in
Innovations in Measles Elimination Innovations in Measles Elimination
"Better health through knowledge sharing and information dissemination "

Images in clinical medicine

Vulva choriocarcinoma

Houssine Boufettal
Pan Afr Med J. 2016; 24:328. doi:10.11604/pamj.2016.24.328.10482. Published 30 Aug 2016



Choriocarcinoma vulva is an exceptional location of gestational trophoblastic tumors. We report the case of a female patient of 23 years who had vulvar mass, painful, sitting at the large right lip and measured five centimeters in diameter. Pelvic ultrasound was normal. Beta-h-CG (human chorionic gonadotrophin) quantitative plasma were highly increased. The staging. The biopsy of the mass objectified choriocarcinoma of vulvar. A methotrexate-based agent chemotherapy was introduced. The outcome was favorable. With a decline of 24 months, no recurrence was noted. Choriocarcinoma vulva is a clinical form of trophoblastic tumors which one must think before all lesions with positive plasma beta-h-CG, especially in a woman of childbearing age and the waning of a pregnancy event. A patient aged 23 presented with a history spontaneous miscarriage which occurred five months earlier consulted for vulvar mass, painful, which gradually increased in size. On examination, the mass was sitting at the large right lip, it was inflammatory, firm and tender to palpation and measured five centimeters in diameter. Pelvic ultrasound was normal. Beta-h-CG (human chorionic gonadotrophin) quantitative plasma were highly increased to 562 000 IU / ml. The staging featuring a thoraco-abdominopelvic CT scan, chest X-ray and ultrasound abdomen and pelvis was normal. The biopsy of the mass objectified choriocarcinoma of vulvar. A methotrexate-based agent chemotherapy was introduced. The evolution was marked by the gradual decline of the mass until it disappears in four months. Plasma beta-h-CG had regressed and were normalized after three months of treatment. The outcome was favorable. With a decline of 24 months, no recurrence was noted.


Corresponding author:
Houssine Boufettal, Centre Hospitalier Universitaire Ibn Rochd, Faculté de Médecine et Pharmacie Hassan II, University of Casablanca, Casablanca, Maroc
mohcineb@yahoo.fr

©Houssine Boufettal et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More images in clinical medicine

 
 
 
 
 
 
 
 
    






PAMJ Images in Medicine and Public Health are archived on Pubmed Central. Access PAMJ archives on PMC here

Volume 33 (May - August 2019)

This image


Share this image:

Filter images [Reset filter]

By language

PAMJ is published in collaboration with the African Field Epidemiology Network (AFENET)
Currently tracked by: DOAJ, AIM, Google Scholar, AJOL, EBSCO, Scopus, Embase, IC, HINARI, Global Health, PubMed Central, PubMed/Medline, Ulrichsweb, More to come . Member of COPE.

ISSN: 1937-8688. © 2019 - Pan African Medical Journal. All rights reserved